期刊文献+

甘精胰岛素联合阿卡波糖及瑞格列奈治疗老年人2型糖尿病的疗效观察 被引量:20

原文传递
导出
摘要 胰岛素抵抗和胰岛β细胞功能减退是2型糖尿病病理生理特征.我们对口服药血糖控制不良的2型糖尿病患者采用长效胰岛素类似物联合阿卡波糖及瑞格列奈进行治疗,以期达到良好的血糖控制,并通过动态血糖监测对治疗效果进行评价.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2010年第11期934-936,共3页 Chinese Journal of Geriatrics
  • 相关文献

参考文献9

  • 1周迎生,迟家敏.老年人糖尿病的流行病学特点[J].中华老年医学杂志,2007,26(8):565-566. 被引量:25
  • 2李剑,徐岩,杨光,李春霖,田慧,成晓玲.甘精胰岛素联合瑞格列奈治疗老年2型糖尿病患者的有效性和安全性分析[J].中国医刊,2008,43(7):28-30. 被引量:11
  • 3Riddle MC, Rosenstock J, Gerich J. The Treat-to- Target Trial: Randomized addition of giargine or human NPH insulin to oraltherapy of type 2 diabetic patients. Diabetic Care, 2003,26 : 3080-3086.
  • 4Plosker GL, Figgitt DP. Repaglinide pharm acoeconomic review of its use in type 2 diabetes mellitus. Pharm Acoeconomies, 2004,22 : 389-411.
  • 5魏爱生,王甫能,陈苹,郅敏,陈发胜,郎江明.甘精胰岛素联合格列美脲及阿卡波糖治疗2型糖尿病患者24小时动态血糖变化[J].中华内分泌代谢杂志,2006,22(4):325-326. 被引量:104
  • 6Enc FY, Imerylyoz N, Akin I, et al. Inhebition of gastric emptying by acarboseis correlsted with GLP-1 response and accompanied by cck release. Am J Physiol, 2001,281:752-763.
  • 7Boland E. Monsod T, Delucia M, et al. Limitations of conventional methods of sell-monitoring of blood glucose lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care, 2001,24 : 1858-1862.
  • 8Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care, 2006,29 : 2730-2732.
  • 9Piper HG, Alexander JL, Shukla A, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics, 2006,118:1176-1184.

二级参考文献13

  • 1程桦,傅祖植,李焱,陈劲松,陆祖谦,黄仕泽,钟光恕,陈玉驹,严棠.四项基本临床试验在非胰岛素依赖型糖尿病优降糖继发失效时的应用[J].中国糖尿病杂志,1994,2(3):130-133. 被引量:24
  • 2张安辉.甘精胰岛素联合格列美脲治疗糖尿病伴磺脲类药物失效的观察[J].中国临床医生杂志,2006,34(2):37-38. 被引量:12
  • 3周健,喻明,贾伟平,李青,李鸣,马晓静,陆蔚,项坤三.应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度[J].中华内分泌代谢杂志,2006,22(3):286-288. 被引量:177
  • 4Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care, 2003,26:3080-3086.
  • 5Klonoff DC. Continuous glucose monitoring: roadmap for 21 st century diabetes therapy. Diabetes Care, 2005,28 : 1231-1239.
  • 6Korytkowski M, Thomas A, Reid L. et al. Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes. Diabetes Care, 2002,25 : 1607-1611.
  • 7Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 diabetes[ J ]. Diabetes Care ,2005,28 ( 2 ) : 260 - 265.
  • 8Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes[ J]. Diabetes Care;2001,24( 11 ) : 1858 - 1862.
  • 9Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring[ J ]. Diabetes Care, 2006,29 ( 12 ) : 2730 - 2732.
  • 10Piper HG,Alexander JL,Shukla A,et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery [ J ]. Pediatrics,2006,118 ( 3 ) : 1176 - 1184.

共引文献134

同被引文献95

  • 1廖勤,梁泽容,屈春梅.两种基础胰岛素类似物——地特胰岛素与甘精胰岛素治疗2型糖尿病临床效果比较[J].实用医院临床杂志,2010,7(4):42-44. 被引量:25
  • 2陆再英,钟南山.内科学.第7版.北京:人民卫生出版社,2010:483-488.
  • 3潘长玉.关注糖尿病血糖治疗达标的安全性隐患[J].中华内分泌代谢杂志,2007,23(4):289-290. 被引量:47
  • 4Nathan DM, Buse JB, Davldson MB,et al. Medical management of hypcr- glyemia in type 2 diabetes AND a consensus algorithm for the initiation and adjustment of therapy[J]. Diabetes Care,2009;32 (5):58.
  • 5Wiesli P, Krayenbiihl P, Uthoff H, et al. Omitting breakfast and hmch af- ter injection of different long-acting insulin prepa-rations at bedtime: a prospective study in patients with type 2 diabetes [J]. Diabetologia, 2009 ;52 : 1816-9.
  • 6Yang SJ Hwang SY,Baik SH,et al.Serum magnesium level is associated with type 2 diabetes in women with a history of gestational diabetes mellitus:the Korea national diabetes program study[J] .J Korean Med Sci,2014,29(1):84-89.
  • 7贾继明,吴立军,吴以岭.西洋参与糖尿病[J].中医药信息,2007,24(6):35-38. 被引量:10
  • 8Guardado-Mendoza R,Prioletta A,Jiménez-Ceja LM,et al.The role of nateglinide and repaglinide,derivatives of meglitinide,in the treatment of type 2 diabetes mellitus[J].Arch Med Sci,2013,9(5):936-943.
  • 9Yang JK,Wang L.PMS Study Collaborative Group.Nateglinide in combination with metformin in Chinese patients with type 2 diabetes mellitus:a post-marketing surveillance study[J].Clin Drug Investig,2013,33(3):185-191.
  • 10Nathan DM,Buse JB,Davldson MB. Medical management of hyperglyemia in type 2 diabetes AND a consensus algorithm for the initiation and adjustment of therapy[J].Diabetes Care,2009,(05):58.

引证文献20

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部